Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

The U.S. Food and Drug Administration has approved its second-ever "biosimilar" drug

FDA Approves Inflectra as ‘Biosimilar’ to Remicade

0
For adults with Crohn's, rheumatoid arthritis, or psoriasis
Defitelio (defibrotide sodium) has been approved by the U.S. Food and Drug Administration to treat a rare

FDA Approves First Tx for Disease Linked to Stem Cell Transplant

0
Hepatic veno-occlusive disease is rare, but fatal
Continuing their push to combat the nation's epidemic of opioid abuse

FDA Wants Generic Opioids to Be Abuse-Deterrent

0
One more step to combat the epidemic of opioid abuse
Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older.

FDA Approves Cinqair for Severe Asthma

0
Lab-developed interleukin-5 antagonist monoclonal antibody helps reduce blood levels of eosinophils
The U.S. Food and Drug Administration has announced that immediate-release opioid pain medications will get new boxed warnings about the dangers of misuse.

FDA Orders Enhanced Warning Labels on Opioid Pain Medications

0
New labeling rules mostly aimed at immediate-release versions of opioids
Anthim (obiltoxaximab) has been approved by the U.S. Food and Drug Administration to treat inhalational anthrax.

FDA Approves Anthim for Treating Inhalation Anthrax

0
Anthim, combined with certain antibacterial drugs, designed to neutralize anthrax toxins
U.S. health officials on Friday gave tentative approval to a field test in the Florida Keys of mosquitoes genetically modified to help curb the spread of the Zika virus.

FDA Gives Tentative Approval to Tests of Gene-Modified Mosquitos

0
Agency says testing the insects in Florida Keys poses little risk to people, animals, the environment
Xalkori (crizotinib) has been approved by the U.S. Food and Drug Administration to treat advanced non-small-cell lung cancer with tumors that have a rare ROS1 gene mutation.

FDA Approves Xalkori for Rare Genetic Form of Lung Cancer

0
Drug approval expanded to include patients with ROS1-positive NSCLC
The U.S. Food and Drug Administration has issued new guidance for reducing the potential transmission risk of Zika virus from human cells

FDA: Guidance to Help Prevent Donor-Related Zika Infection

0
Part of FDA's ongoing efforts to protect HCT/Ps and blood products from Zika virus transmission
A new boxed warning is needed on the Essure implantable birth control device

FDA Adds Boxed Warning Requirement to Essure Device

0
In addition, manufacturer Bayer must conduct further study of real-world risks